Actelion re-elects board members

Actelion has re-elected three of its board members at its annual general meeting (AGM).

The pharmaceutical company held the AGM in Basel in Switzerland earlier this week, with more than 300 shareholders attending the event.

As part of the proceedings, Werner Henrich, Armin Kessler and Jean Malo were all voted back on to the board of Actelion for a further three-year term.

The board of directors at the company has ten members and is chaired by Robert Cawthorn.

Other issues resolved at the AGM included the shareholders approving the company’s financial results for 2009, as well agreeing to the appointment of Ernst & Young as the firm’s statutory auditors for this year.

Last month, Actelion released its results for the first quarter of 2010, in which the company recorded net revenue of 501.7 million Swiss francs (306 million pounds).

Jean Paul Clozel, managing director and chief executive officer of Actelion, said at the time: “I am very pleased with our performance this quarter, including the robust demand for our products and our strong financial performance.”